Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension
Clinical trial NCT00686803 · COMPLETED
Trial details
- NCT number
- NCT00686803
- Sponsor
- Palatin Technologies, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2008-07-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.